{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:01:01Z","timestamp":1790694061425,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574817"],"award-info":[{"award-number":["82574817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202986"],"award-info":[{"award-number":["82202986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010135"],"award-info":[{"award-number":["2025A1515010135"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012867"],"award-info":[{"award-number":["2024A1515012867"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515220017"],"award-info":[{"award-number":["2023A1515220017"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J0466"],"award-info":[{"award-number":["2025A03J0466"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115378","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:18:05Z","timestamp":1773681485000},"page":"115378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sunitinib induces immunogenic cell death through eIF2\u03b1 phosphorylation to potentiate immunotherapy in HCC"],"prefix":"10.1016","volume":"29","author":[{"given":"Yimei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhou","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4035-7377","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115378_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.115378_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.115378_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115378_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115378_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115378_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2026.115378_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib10","first-page":"187","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.115378_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115378_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-019-0272-7","article-title":"Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies","volume":"17","author":"Kepp","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115378_bib13","article-title":"Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.115378_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.115378_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4161\/onci.1.2.19026","article-title":"Trial watch: Chemotherapy with immunogenic cell death inducers","volume":"1","author":"Vacchelli","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2026.115378_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrd2012","article-title":"Sunitinib maleate","volume":"5","author":"Atkins","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115378_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115378_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2016.07.044","article-title":"Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model","volume":"66","author":"Li","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.isci.2026.115378_bib19","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2012.45.8372","article-title":"Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial","volume":"31","author":"Cheng","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115378_bib20","article-title":"Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer","volume":"7","author":"Liu","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2026.115378_bib21","first-page":"115","article-title":"Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer","volume":"3","author":"Liu","year":"2018","journal-title":"J. Immunol. Res. Ther."},{"key":"10.1016\/j.isci.2026.115378_bib22","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1182\/blood-2007-02-075945","article-title":"Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses","volume":"111","author":"Hipp","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115378_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.115378_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.trecan.2017.07.002","article-title":"The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy","volume":"3","author":"Rufo","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib25","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: Present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2026.115378_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.115378_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","article-title":"Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma","volume":"164","author":"Haber","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.115378_bib29","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1158\/1078-0432.CCR-20-1497","article-title":"Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma","volume":"26","author":"Bassaganyas","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115378_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102351","article-title":"Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma","volume":"54","author":"Xu","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.115378_bib31","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115378_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.755433","article-title":"Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib","volume":"11","author":"Scirocchi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.115378_bib33","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/acs.jmedchem.3c01785","article-title":"Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115378_bib34","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/acs.jmedchem.2c01798","article-title":"Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115378_bib35","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Glabridin-Gold(I) Complex as a Novel Immunomodulatory Agent Targeting TrxR and MAPK Pathways for Synergistic Enhancement of Antitumor Immunity","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.115378_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106731","article-title":"SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer","volume":"190","author":"Lu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.115378_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.115378_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001038","article-title":"Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response","volume":"8","author":"Qi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.115378_bib39","doi-asserted-by":"crossref","first-page":"29189","DOI":"10.1021\/jacs.4c11636","article-title":"PAMAM-Based Polymeric Immunogenic Cell Death Inducer To Potentiate Cancer Immunotherapy","volume":"146","author":"Huang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.isci.2026.115378_bib40","doi-asserted-by":"crossref","first-page":"26195","DOI":"10.1021\/jacs.5c02774","article-title":"Metal-Phenolic Outer Membrane Vesicles for Cancer Radioimmunotherapy","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.isci.2026.115378_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400068","article-title":"Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy","volume":"13","author":"Pan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.isci.2026.115378_bib42","first-page":"31","article-title":"Genetically engineered nanomodulators elicit potent immunity against cancer stem cells by checkpoint blockade and hypoxia relief","volume":"38","author":"Pan","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.isci.2026.115378_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115378_bib44","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/gutjnl-2020-322196","article-title":"High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39(+)CD8(+) T cells","volume":"70","author":"Liu","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.115378_bib45","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:38:18Z","timestamp":1790692698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226007534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226007534"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115378","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sunitinib induces immunogenic cell death through eIF2\u03b1 phosphorylation to potentiate immunotherapy in HCC","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115378"}}